These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1447397)

  • 1. N-acetylation polymorphism and diabetes mellitus among Saudi Arabians.
    el-Yazigi A; Johansen K; Raines DA; Dossing M
    J Clin Pharmacol; 1992 Oct; 32(10):905-10. PubMed ID: 1447397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylator phenotypes of Saudi Arabians by a simplified caffeine metabolites test.
    el-Yazigi A; Chaleby K; Martin CR
    J Clin Pharmacol; 1989 Mar; 29(3):246-50. PubMed ID: 2723111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified and rapid test for acetylator phenotyping by use of the peak height ratio of two urinary caffeine metabolites.
    el-Yazigi A; Chaleby K; Martin CR
    Clin Chem; 1989 May; 35(5):848-51. PubMed ID: 2566399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylator phenotypes of Jordanian diabetics.
    Irshaid Y; al-Hadidi H; Abuirjeie M; Latif A; Sartawi O; Rawashdeh N
    Eur J Clin Pharmacol; 1992; 43(6):621-3. PubMed ID: 1493843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acetylator phenotypes of Saudi Arabian diabetics.
    Evans DA; Paterson S; Francisco P; Alvarez G
    J Med Genet; 1985 Dec; 22(6):479-83. PubMed ID: 4078878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary selenium in healthy and diabetic Saudi Arabians.
    El-Yazigi A; Legayada E
    Biol Trace Elem Res; 1996 Apr; 52(1):55-63. PubMed ID: 9156539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation phenotypes and biological variation in a French Caucasian population.
    Pontes ZB; Vincent-Viry M; Gueguen R; Galteau MM; Siest G
    Eur J Clin Chem Clin Biochem; 1993 Feb; 31(2):59-68. PubMed ID: 8467011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus.
    Madácsy L; Szórády I; Sánta A; Barkai L; Vámosi I
    Child Nephrol Urol; 1992; 12(4):192-6. PubMed ID: 1473091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between slow acetylator status and spontaneous lupus erythematosus.
    Kumana CR; Chan MM; Wong KL; Wong RW; Kou M; Lauder IJ
    Clin Pharmacol Ther; 1990 Aug; 48(2):208-13. PubMed ID: 2379389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
    Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G
    Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipyrine, coumarin and glipizide affect n-acetylation measured by caffeine test.
    Klebovich I; Rautio A; Salonpää P; Arvela P; Pelkonen O; Sotaniemi EA
    Biomed Pharmacother; 1995; 49(5):225-7. PubMed ID: 7579000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation polymorphism of caffeine in a Japanese population.
    Hashiguchi M; Ebihara A
    Clin Pharmacol Ther; 1992 Sep; 52(3):274-6. PubMed ID: 1526084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between chlorpropamide-alcohol flushing and fast acetylator phenotype in type I and type II diabetes.
    Bonisolli L; Pontiroli AE; De Pasqua A; Calderara A; Maffi P; Gallus G; Radaelli G; Pozza G
    Acta Diabetol Lat; 1985; 22(4):305-15. PubMed ID: 3868908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities.
    Fuchs P; Haefeli WE; Ledermann HR; Wenk M
    Eur J Clin Pharmacol; 1999 Jan; 54(11):869-76. PubMed ID: 10027663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple test for acetylator phenotype using caffeine.
    Grant DM; Tang BK; Kalow W
    Br J Clin Pharmacol; 1984 Apr; 17(4):459-64. PubMed ID: 6721992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylator phenotyping via analysis of four caffeine metabolites in human urine by micellar electrokinetic capillary chromatography with multiwavelength detection.
    Guo R; Thormann W
    Electrophoresis; 1993; 14(5-6):547-53. PubMed ID: 8354241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylator phenotypes in diabetes mellitus.
    Stryjek-Kamińska D; Malczewski B; Kopeć A; Rowińska-Marcińska K
    Acta Diabetol Lat; 1988; 25(1):41-8. PubMed ID: 3407376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine acetylator phenotyping during maturation in infants.
    Pariente-Khayat A; Pons G; Rey E; Richard MO; D'Athis P; Moran C; Badoual J; Olive G
    Pediatr Res; 1991 May; 29(5):492-5. PubMed ID: 1896253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells.
    Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of acetylator phenotype in Caucasians with caffeine.
    Hildebrand M; Seifert W
    Eur J Clin Pharmacol; 1989; 37(5):525-6. PubMed ID: 2598993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.